Authors

• Vivian H. Shih (ORCID: https://orcid.org/0000-0003-0853-4210)
• Annika Åstrand (ORCID: https://orcid.org/0000-0002-4231-6682)
• Ranran Dai (ORCID: https://orcid.org/0000-0003-4044-2615)
• Yuhui Yao (ORCID: https://orcid.org/0009-0009-9450-2848)
• Viktoría Werkström
• Kefang Lai (ORCID: https://orcid.org/0000-0001-7994-7296)
• Maria Jison
• Hae‐Sim Park (ORCID: https://orcid.org/0000-0003-2614-0303)
• Dejun Sun (ORCID: https://orcid.org/0000-0003-0841-1501)
• Yajuan Zhang (ORCID: https://orcid.org/0009-0006-1672-4806)
• Nanshan Zhong (ORCID: https://orcid.org/0000-0003-2274-1427)
• David Cohen (ORCID: https://orcid.org/0000-0001-7318-8567)

Institutions

• Ruijin Hospital (CN)
• First Affiliated Hospital of Guangzhou Medical University (CN)
• AstraZeneca (Netherlands) (NL)
• AstraZeneca (Singapore) (SG)
• Inner Mongolia People's Hospital (CN)
• AstraZeneca (Poland) (PL)
• AstraZeneca (Finland) (FI)
• AstraZeneca (Germany) (DE)
• Ajou University (KR)
• Guangzhou Medical University (CN)

Publication Details

Journal

Immunotherapy

Published

2025-08-13

DOI

https://doi.org/10.1080/1750743x.2025.2550237

Primary Topic

Asthma and respiratory diseases

Type

article

Field-Weighted Citation Impact

0.00